CO2 Laser and Open Surgery for T1N0 Glottic SCC With Anterior Commissure Involved
Squamous Cell Carcinoma of Glottis
About this trial
This is an interventional treatment trial for Squamous Cell Carcinoma of Glottis focused on measuring CO2 laser surgery, open surgery, multicenter prospective, randomized, controlled clinical studies, T1N0 squamous cell carcinoma of glottis with anterior commissure involved
Eligibility Criteria
Inclusion Criteria:
- T1N0 SCC of glottic carcinoma with anterior commissure involve
- No nodal metastasis and distant metastasis
- All patients must have CT/MR and electronic laryngoscope test before surgery and after surgery
- Expected lifetime>1 year
- Patients and families agreed to participate in the test and sign the informed consent
- Without cognitive impairment.
Exclusion Criteria:
- With severe cardiac insufficiency Liver and kidney function is not complete systemic infection patients
- Patients with pregnancy and lactation
- Have surgery contraindications
Sites / Locations
- Sun Yat-sen University Cancer CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
CO2 laser surgery
Open surgery
CO2 Laser surgery for T1N0 Glottic Squamous Cell Carcinoma With Anterior Commissure Involved. All patients, under general anesthesia, underwent endoscopic excision of the lesion using a carbon dioxide (CO2) laser (Sharplan 100) coupled with a microscope (Zeiss) set to an output power of between 5 and 12 W in superpulse mode. The lesion's resection was accomplished in a radical fashion, with a free margin of 2 mm. For lesions which involved the anterior commissure, the excision plane always uncovered the cartilage.
Open Surgery for T1N0 Glottic Squamous Cell Carcinoma With Anterior Commissure Involved. open surgery :Frontolateral Vertical Partial Laryngectomy or laryngofissure with cordectomy was accomplished in a radical fashion, with a free margin of 2 mm.